VisualSonics VevoStrain Technology Provides Earlier Access to Left Ventricular Dysfunctions
April 14 2011 - 1:57PM
Business Wire
VisualSonics Inc., a leader in real time, in vivo,
high-resolution micro-imaging systems and a wholly-owned subsidiary
of SonoSite Inc., announced today that its
VevoStrain™ technology has been featured on the cover of the April
15, 2011 issue of Circulation Research, Journal of the American
Heart Association.
VevoStrain provides advanced imaging and quantification
capabilities to study sensitive movements in the heart muscles –
specifically the myocardium. The VevoStrain technology augments
high-resolution imaging capabilities of high-frequency ultrasound
with highly sensitive measurements of subtle variations in the
myocardium. The VevoStrain software enables tracking of wall
motions in the heart, including the entire heart as well as defined
regions within the heart. Measurement capabilities include
quantification of displacement, velocity, strain and strain rate.
Researchers1 at Brigham and Women’s Hospital, Harvard Medical
School present the utility of VevoStrain technology as a non
invasive, highly sensitive and rapid cardiac phenotyping tool in
their seminal paper on in vivo strain analysis.
Ronglih Liao, MD, Associate Professor of Medicine, Harvard
Medical School said, “We believe that with strain analysis, we now
have a very effective and efficient method for non-invasively
detecting early cardiac performance irregularities in mice. While
recognizing that this method requires special expertise and
experience to implement, we are very excited about prospects for
applying these analyses in future studies of experimental
therapeutics.”
The VevoStrain software is emerging as the new state-of-the-art
assessment tool for quantifying myocardial mechanical function and
deformation, replacing Tissue Doppler imaging, which has been used
in the past. Additional features of the software include
measurement of cardiac wall motion abnormalities, dyssynchrony
(delayed ventricular activation and contraction) and myocardial
mechanics.
More information on VevoStrain software is available at:
http://www.visualsonics.com/vevostrain.
About VisualSonics
VisualSonics is the world leader in real time, in vivo,
high-resolution micro imaging systems designed specifically for
preclinical research and a wholly-owned subsidiary of SonoSite,
Inc. (Nasdaq:SONO). The Company’s cutting edge technologies
allow researchers at the world’s most prestigious pharmaceutical
and biotechnology companies, hospitals and universities to conduct
research in cardiovascular, cancer, neurobiology and developmental
biology areas. The micro imaging technologies support research
applications that include genetic research, phenotypic studies and
drug development. VisualSonics micro imaging platforms combine
high-resolution, real time in vivo imaging at reasonable cost with
ease-of-use and quantifiable results.
About SonoSite
SonoSite, Inc. (www.sonosite.com)
is the innovator and world leader in bedside and point-of-care
ultrasound and an industry leader in ultra high-frequency
micro-ultrasound technology and impedance cardiography equipment.
Headquartered near Seattle, the company is represented by fourteen
subsidiaries and a global distribution network in over 100
countries. SonoSite’s small, lightweight systems are expanding the
use of ultrasound across the clinical spectrum by cost-effectively
bringing high-performance ultrasound to the point of patient
care.
1 Bauer M, Cheng S, Liao R; Echocardiographic Speckle-Tracking
Based Strain Imaging for Rapid Cardiovascular Phenotyping in Mice;
CIRCRESAHA/2010/239574-R1
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jul 2023 to Jul 2024